Stay updated on ELVN-001 for CML Treatment Clinical Trial
Sign up to get notified when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.

Latest updates to the ELVN-001 for CML Treatment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Fadi Haddad, MD as a study contact and removed Koji Sasaki, MD. The page now shows Last Update Posted (Estimated) and revision v3.3.2.SummaryDifference0.2%

- Check28 days agoChange DetectedThe government funding lapse notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedNo significant changes detected between the screenshots; the study details page appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedKey updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).SummaryDifference3%

- Check78 days agoChange DetectedUpdated page revision to v3.1.0 and added a large set of contact phone numbers; removed an older capitalization variant of a disease term. The main impact is expanded contact information on the page.SummaryDifference0.2%

- Check93 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' link was removed, with no other significant content changes.SummaryDifference0.2%

Stay in the know with updates to ELVN-001 for CML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.